Chin Filler

In short: Chin filler is a non-surgical augmentation method that increases the profile chin projection by injecting hyaluronic acid or calcium hydroxyapatite fillers into the pogonion area. Broad, angular chin in men; The ideal of a soft, tapered chin in women. The effect lasts 12-24 months and mental neuroprotection should be considered.

Definition and Aesthetic Dimension of Jaw Anatomy

Chin filler is an injection treatment that restores or enhances profile aesthetics by volumetric augmentation of the mandibular anterior region. The chin is the most anterior element of the facial profile and forms the basis of profile harmony. According to Nesbitt-McNamara cephalometric analysis, in the ideal profile, the pogonion (the most forward point of the jaw tip) should be synchronous with the nasofrontal vertical (NFV) line or 2-3 mm posterior to the NFV. Posterior displacement (retrognathia) of the pogonion creates the appearance of an aged, frail individual; Anterior displacement (prognathism), masculinization, strong jawline, and excessive augmentation can create a "Frankenstein" appearance.

Gender-Specific Differences in Jaw Anatomy: The male chin generally presents a wider, more angular (sharp), more anterior-projected, square-shaped and "strong" appearance. The female chin is more tapered (tapered), softer (softer borders), shorter vertical dimension (lower lower face height), and rounded or V-shaped. These differences are caused by the gonial angle (the angle of the jaw edge and the lateral edge of the jaw), ramus width and anterior pogonion projection. Restoring these anatomical differences in gender-affirming patients with make-up is critical in terms of aesthetic and psychosocial satisfaction.

Jaw Region Anatomy and Vascular Network

Bone Structure: It is defined by the jaw, mandibular symphysis and anterior body region. Anatomical reference points such as pogonion, gnathion (lowest point), menton (mental midline - point below the midline) determine the injection targets. Mental nerve (branch of the inferior alveolar nerve) emerges from the bone hole located 1.5-2 cm lateral to the mental foramen, symphysis; This is the most critical "danger zone" during injection. The mental nerve provides sensory innervation to the jaw, lower lip and lower gingiva (gum). Needle penetration close to the mental foramen carries the risk of paresthesia (numbness, burning), hypoesthesia (loss of sensation), or dysesthesia (abnormal sensation).

Soft Tissue Layers (Surface to Deep):

• Skin and dermis: The thickness of the chin skin is on average 1.5-2 mm; It has a thicker, stronger collagen network than other parts of the face.
• Subcutaneous fat and SMAS: There are also peribuccal fat compartments in the chin, but mentalis muscle insertions are prominent in the chin area.
• Mentalis muscle (Mentalis Muscle): It consists of thin, short muscle fibers on the pogonion. This muscle's function is to "gather" the mandibular anterior region by pulling the lower lip upwards. In over-augmentation chin filler, there is a risk of "cobblestone chin" (dimpling, spider web-like restricted movement) due to the additional contraction load of the mentalis muscle.
• Periosteum: The layer on the bone that determines whether the HA/CaHA injection is placed supraperiosteal (on the bone) or subperiosteal (under the bone).

Vascular Anatomy — Mental Artery and Facial Artery Network:

• Mental artery: It is the terminal branch of the inferior alveolar artery and originates from the mental foramen and rests on the pogonion area. In superficial mandibular anatomy, the chin is superficial under the skin.
• Facial artery: It supplies the para-pogonion region, on the inferior jawline, on the medial side of the mental artery. High pressure or needle penetration during injection carries the risk of vascular occlusion—a rare, but serious, result of skin necrosis.
• Supraperiosteal injection direction: When the filler is placed on the bone (on the outside of the periosteum), the risk of hematoma and vascular occlusion is minimized. Superficial injection (intradermis) increases the risk of vascular penetration.

Indications (Who is Suitable for?)

Aesthetic Indications:

• Microgenia (Small Jaw / Retrognathia): Congenitally small, retracted chin; profile mismatched or poor appearance. In the profile photo, if the pogonion remains behind the NFV line, augmentation is indicated.
• Asymmetric Chin: One side is more promin than the other; Unilateral selective injection restores symmetry.
• Lack of Profile Projection: Jaw volume loss and resorption due to aging. The combination of midface lifting and chin augmentation to support jawline definition is frequently requested.
• Jawline Definition and Contour Lengthening: If the chin tip is desired to indicate a more prominent, angular — male aesthetic ideal or gender-affirming male (FtM).
• Lip-Jaw Proportion Correction: Disproportion of over-augmented lips with weak chin — chin augmentation restores lip-chin harmony.

Medical Indications:

• Temporomandibular Joint (TMJ) Dysfunction Compensation: TMJ arthritis, posterior mandibular displacement — anterior jaw augmentation can increase anterior dentition space with mandibular forward positioning (adjunct to orthodontic therapy).
• Refinement After Orthognathic Surgery: Refining the pogonion projection or conical contour after genioplasty.

Contraindications

• History of Mental Nerve Damage: Mental nerve injury from previous surgery (wisdom tooth extraction, implant, genioplasty) or trauma — numbness, if dysesthesia already exists, filler injection may aggravate paresthesia. High risk of malpractice litigation.
• Active Dental Infection: Caries, periodontitis, pus drainage from oral cavity to jaw area. Injection may spread infection into deep tissue — risk of abscess, cellulitis.
• Heavy Anticoagulation (INR > 3 or Dual Antiplatelet): Hematoma risk is high; A pre-procedural coagulation status check is recommended.
• Mentalis Muscle Atrophy (Rare): In neuromuscular diseases such as myasthenia gravis, if there is mentalis muscle weakness, there is a risk of a "hanging" jaw appearance after filler resorption.
• Pregnancy and Breastfeeding: FDA category C; safety data is insufficient. Elective procedure—postpartum postponement ideal.

Product Selection (Which HA/CaHA?)

Hyaluronic Acid (HA) Products:

• Juvéderm Volux (FDA Approved 2020 Chin Augmentation): Especially designed for chin filler, "G-prime" (viscoelastic modulus) 54 Pa — high hardness, projection and contour stability are ideal. Particles 0.8-1.2 µm, cross-linking high. The duration of effect is 12-18 months. "Strong jawline" look is ideal for male patients.
• Juvéderm Voluma XC: Slightly softer (G-prime 40 Pa), HA 24 mg/mL; It is long-acting (12-24 months). Suitable for female patients or those who prefer subtle augmentation.
• Restylane Lyft: Medium-high cross-linking, particles 1.0-1.2 µm, G-prime ~35 Pa. Good for chin anterior body; The duration of effect is 9-12 months.

Calcium Hydroxyapatite (CaHA) Products:

• Radiesse (CaHA): 30 mg/mL calcium hydroxyapatite particles + carboxymethylcellulose gel carrier. It provides "biostimulation" (collagen production provocation) for jaw bone augmentation. Immediate volume + 6-12 months additional collagen deposition = total 12-24 months effect. For male patients, bone-like protraction and stability are ideal. Price higher than HA (cost-effectiveness: HA reinjection in 3-4 months vs. CaHA 12-18 months).

Product Selection Algorithm:

• Male, strong jawline target, long-term investment: Volux or Radiesse — high G-prime, strong projection, 12-18+ months effect.
• Female, subtle, soft contour: Voluma or Lyft — medium firmness, natural feel, 12-18 months.
• Touch-up / Repeat patient: HA preferred (reverse-with hyaluronidase option) — CaHA removal is difficult.
• Budget conscious, 6-9 months satisfaction: HA (cheaper, despite the risk of frequent reinjection).

Technique and Approach

Pre-Procedure Preparation:

1. Consultation and Design: Profile view, Nesbitt-McNamara NFV line, pogonion position, masseteric border, mental foramen palpation. Photo (frontal, profile, 45°). Expectation management — “natural enhancement” vs. "dramatic change".
2. Anesthesia Selection:
   • Local Nerve Block (Ideal): Inferior alveolar nerve block (IAN) + buccal infiltration, 1:100,000 epinephrine + lidocaine 2% 3-5 mL. It numbs the entire anterior mandible and provides pain-free injection. Extraoral approach or intraoral; preference physician expertise.
   • Infiltration Anesthesia: Direct infiltration of pogonion and paramental points - although invasive, local block of menos does not require a technician, it is not full anesthesia.
   • Topical Anesthesia: For insufficient chin injection alone; augmentation pain, topical EMLA/lidocaine insufficient due to deep injection depth.
3. Sterilization and Branding: Sterilize hands and injection area with Chlorhexidine 0.05%. Reference points are marked: pogonion (anterior-most), gnathion (inferior-most), paramental points (bilateral medial ramus-anterior mandible junction).

Injection Technique — Supraperiosteal Bolus:

• Needle/Cannula Selection: Cannula PREFERENCE (blunt 25-27G, 38-50 mm) — safe for the area close to the mental foramen. If needle (25G) is preferred, very careful anatomical mapping and negative aspiration test (vein control) are mandatory.
• Entry Point — Pogonion Injection: Pogonion anterior point or 3-5 mm superior-lateral, 1-2 mm from the skin surface. The cannula/needle advances along the bone surface (supraperiosteal). Initial bolus: 0.5-1 mL HA/CaHA for pogonion anterior projection. Mental foramen distance is checked — lateral position (>1.5 cm from the symphysis midline).
• Paramental Injections: Bilateral, along the medial mandibular border, to the anterior body and ramus junction. Each side: 0.3-0.5 mL — mandibular edge definition and lateral projection. Total per session: 1-2 mL (male: 1.5-2 mL; female: 1-1.5 mL).
• Depth Control: Supraperiosteal (on bone) placement — palpation checks the "bony ridge". Very superficial (dermis) → vascular occlusion risk; too deep (periosteal cavity) → risk of osteoperiodontal nerve trauma.
• Bolus vs. Linear Threading: Chin HA/CaHA, usually bolus technique (fixed points) — anterior stability and definite protraction. Linear threading ("sweeping") is an alternative, but with greater risk of hematoma.

Dose and Volume

Virgin Patient (First-time): 0.5-1 mL total — pogonion 0.3-0.5 mL + paramental bilateral 0.1-0.25 mL per side. Conservative approach; After 2-3 weeks, the final result is observed. Top-up option 4 weeks later.

Repeat Patient / Aggressive Augmentation: 1-2 mL total — for male aggressive "strong chin" target, 1.5-2 mL; If the woman chooses subtle, 1 mL. Per-session maximum, FDA/dermatology standard practice 2 mL chin HA/CaHA—exceeding dose, over-augmentation, cobblestone risk.

Touch-up Timing: After 2-4 weeks, if the swelling has completely subsided, the final volume is evaluated and an additional dose is decided. Patients often report "I want a little more definition"—0.3-0.5 mL top-up is common.

Procedure Flow (Step by Step)

1. Consultation (5-10 minutes): Set a goal, take photos, design. Discuss jaw asymmetry, mental foramen risk, profile harmony.
2. Anesthesia (5 minutes): Local nerve block (IAN + buccal) or infiltration, waiting 2-3 minutes — full anesthesia control (toothpick scratch test).
3. Sterilization and Branding (2-3 minutes): Chlorhexidine, pogonion + paramental points are marked.
4. Injection (5-10 minutes): Cannula/needle entry, pogonion bolus, paramental bilateral injections. Aspiration test, slow deposition, massage optional.
5. Post-Procedure Management (5 minutes): Ice 10 minutes, gentle massage, post-op instructions.

Total Procedure Time: 30-45 minutes (consultation + anesthesia + injection + recovery).

Results and Duration of Effect

Immediate (After 0-2 Hours): Swelling begins, the chin becomes noticeably larger. Patients report "looks big, feels stiff". Bruising is minimal (variable depending on needle/cannula selection). Since HA does not move, the shape is immediate stable.

24-72 Hours (Edema Peak): Edema is maximum, the chin appears 3-5 mm thicker. Bruising (ecchymosis) is evident (blue-purple), especially if a needle was used. Itching, tingling are possible. Patients prefer social withdrawal. Recommendations: ice (20 minutes, every 4-6 hours), ibuprofen 400 mg every 6 hours (AVOID aspirin - hematoma aggravate), elevation (horizontal lying increases chin height, edema drains)

1-2 Weeks (Recovery): The edema gradually decreases and the bruise turns yellow-green. The final result is seen 50-70% of the time. The chin is more defined, the projection is clear. Masker can be turned off, public activities return.

2-4 Weeks (Final Result): Edema completely, bruise resolved. HA/CaHA fully integrated — "true" augmentation volume stabilization. Natural appearance, "natural appearance, but obvious improvement" patient report. Satisfaction is generally high.

Effect Duration (Maintenance): HA 12-18 months; CaHA 12-24 months (biostimulation extra 6-12 months). Reinjection: When HA remains 30-40% of baseline (9-12 months); CaHA postponement (18-24 months).

Risks and Complications

Common (Transient, self-resolve):

• Edema and Bruising: Universal, expected; 1-2 weeks resolution. Depends on bruising needle/cannula choice, hemostasis, anticoagulant use.
• Pain and Hyperesthesia: Procedural pain, post-procedural soreness 2-3 days. Mental nerve irritation numbness/paresthesia transient (due to nerve swelling), usually resolves in 1-2 weeks.
• Temporary Asymmetry: Unilateral edema, injection error — if the edema subsides, reshaping is possible.

Serious Complications (Rare, Risk of Permanence):

• Mental Nerve Paresthesia (Permanent): Needle penetration near mental foramen, local anesthesia overspill, or injection volume mental nerve compress → persistent numbness, lower lip burning, chin anesthesia. Treatment: steroid injection, nerve growth factor (NGF) graft (rare), surgical nerve exploration (rare). Prevention: cannula preference, mental foramen mapping, lateral injection 2 cm laterally.
• Vascular Occlusion: Mental artery penetration or compression, risk of skin necrosis. Blanching, livedo reticularis, black necrosis 24-72 hours. Treatment: immediate hyaluronidase 200 U (HA cases), aspirin, pentoxifylline, nitrate spray, warm compress. Prevention: negative aspiration, slow injection, cannula technique.
• "Cobblestone Chin" (Mentalis Muscle Dimpling): After overaugmentation (1.5+ mL pogonion), mentalis muscle hyperfunction; skin dimple, "orange peel" texture, smooth smile. Treatment: HA partial removal (hyaluronidase), Botox mentalis (3-5 U) — controversial, mas atrophy risk. Prevention: conservative dose, mentalis muscle anatomy respekt.
• Asymmetry (Persistent): Unilateral underfill or overfill, paramental selective injection error. Treatment: touch-up, unilateral correction, 2-3 weeks post-operative waiting.
• Allergic Reaction (Very Rare): HA allergy (<1:1,000,000), immediate or delayed (granulomatous foreign body reaction). Treatment: steroid intralesional, HA removal (surgical excision rare).

Healing Process and Downtime

Downtime (Social / Professional): 3-7 days — bruising is noticeable, difficult to cover with make-up; Sickleave or WFH is recommended for "public facing" jobs. Swelling decreases significantly in 2-3 weeks, but residual softness is possible for 1 month.

Activity Restrictions (First 1-2 Weeks):

• Intense exercise (gym, cardio, yoga) — hematoma risk, edema delay. Light walking is OK after 48 hours.
• Thermal exposure (sauna, hot shower, sun) — capillary dilation, edema aggravate. Cool/cold preferred.
• Alcohol and NSAID (aspirin, ibuprofen overuse) — bleeding risk, hematoma (ibuprofen OK after 48 hours, aspirin avoid).
• Face pressure / manipulation — avoid massage, sleeping on face, strap/headband — risk of HA shift.
• Straws and suction — oral pressure jaw minimal trauma risk (rare).

Recovery Milestone: Week 1 — edema reduced by 50-60%, bruising yellow; Week 2 — edema >90%, bruising minimal; Week 3-4 — final stabilization, activity return, makeup-free public OK.

Price and Package in Türkiye (2026)

Chin filler pricing depends on product selection, volume, city, and hospital prestige:

Hyaluronic Acid (HA — Voluma, Lyft, Volbella): 12,000-25,000 TL per session (0.5-1.5 mL). Average: 15,000-20,000 TL.

Juvéderm Volux (FDA-Approved Chin): 18,000-30,000 TL per session (1-1.5 mL special pricing).

Calcium Hydroxyapatite (CaHA — Radiesse): 20,000-35,000 TL per session (1-1.5 mL) — 5,000-10,000 TL higher than HA; Patient recouped due to long-term value (12-18+ months vs. HA 12 months).

Package Options: Combination (jawline contour + chin filler) 25,000-45,000 TL; Botox + chin filler (marionette + chin combo) 20,000-35,000 TL.

Region-Specific Subtleties and Gender-Affirming Techniques

Male Jaw Augmentation ("Strong Jawline"): Pogonion anterior projection MAX, 1.5-2 mL Volux/Radiesse, square-angular gonial angle emphasis. Paramental lateral augmentation, masseter border sharp. "Square-jawed" masculine is ideal. Critical for gender-affirming male (FtM) patients.

Female Chin Augmentation ("Soft, Tapered"): Pogonion subtle, 0.8-1.2 mL HA (Voluma), tapered, V-shaped contour. Lateral excess is avoided — risk of over-augmentation. Paramental selective (medial-anterior), V-line soft taper is ideal. Essential for gender-affirming female (MtF) patients.

Mental Foramen Protection Protocol: Mandatory for each chin injection — 1.5-2 cm from the lateral symphysis, entry, palpation, anatomical reference (mental groove, alveolar ridge height), cannula (not a needle), blunt approach. If the injection time is >30 minutes, there is a risk of mental nerve edema - split the sessions (first 0.5-1 mL, 2 weeks later top-up).

Mentalis Muscle Rispetto: Mentalis muscle key role in jaw anatomy — over-distention dimpling risk. Bolus injection is supraperiosteal (on the bone), not superficial (dermis) — mentalis integrity protection. Mentalis dynamic: movement in smiling, whistling, frowning - the ability of the muscle is preserved.

Op. Dr. Hamza Gemici Comment

"Chin filler is the most powerful non-surgical intervention of profile aesthetics. Pogonion's even 2-3 mm anterior shift transforms the harmony of the entire facial profile. Male patients come for 'strong, masculine chin', women for 'soft, definition'; in a gender-affirming context, chin augmentation is as gender-specific as nasal rhino. The risk of mental nerve paresthesia is minimal — cannula preference, anatomical with mapping, conservative titration. Caused by aggressive pogonion overfill — supraperiosteal bolus, 1-1.5 mL rule respect, FDA-approved best-in-class in Volux chin fillers; HA/CaHA selection in terms of radiesse biostim benefit, individual according to patient expectation, budget, maintenance tolerance.”

Related Terms

You can access other wiki terms related to chin filler on the following pages: cheek filler, under-eye filler, nasolabial filler, marionette filler, filler, hyaluronic acid, jawline contour, nefertiti lift.

Frequently Asked Questions

1. Are Chin Fillers Different in Men and Women?

Answer: Yes, there is a significant difference. Male chin should be wide, angular, square-shaped, projection high; female chin tapered, soft, V-shaped ideal. Injection volume, location (pogonion anterior vs. subtle enhancement), product selection (Volux strong male vs. Voluma soft female) are adapted to gender-specificity. Gender-affirming MtF chin tailored feminization; FtM bold masculine augmentation is required.

2. What is the Risk of Mental Nerve Pain? Is Numbness Permanent?

Answer: Mental nerve paresthesia (numbness, burning) results from needle penetration near the mental foramen injection. Risk ~1-2%; Numbness is usually transient (4-12 weeks), due to post-procedural nerve swelling. Permanent paresthesia <0.1% — rare. Prevention: cannula preference, 1.5-2 cm lateral injection, negative aspiration, conservative dose. Treatment of permanent numbness: intralesional steroid, nerve growth factor, surgical exploration (rare).

3. How much difference can be seen in the profile photo?

Answer: 1-2 mL of chin filler creates significant visual change in profile silhouette. Pogonion forward 2-3 mm shift, Nesbitt-McNamara NFV line proximity improve, "weak profile" etc. "strong jawline" perception transforms dramatically. Photo comparison (pre-post, 1 month) impressive — especially male strong augmentation or FtM gender-affirming cases.

4. Is Chin Filler an Alternative to Plastic Surgery?

Answer: Partial alternative — non-surgical. Genioplasty (surgical jaw advancement) for permanent, profound augmentation goals; filler reversible, titrable, downtime minimal. Severe retrognathia, filler insufficient for orthognathic surgery candidates — adjunct to surgery. Moderate cases, subtle enhancement, patient surgery risk/recovery intolerance → filler excellent choice.

5. How is it compatible with a beard? Does a Padded Chin Look Incompatible with a Beard?

Answer: No — beard has the potential to mask chin augmentation. Beard heavy, hide chin contour; beard light/stubble, augmentation more visible, "sharp jawline" clearly visible. If male patients prefer a "clean-shaven look", augmentation benefit max. Beard style selection, patient aesthetics preference — filler compatibility is not a problem, it depends on the choice of beard + filler harmony elective.

6. Does Filler Feel Natural When Laughing?

Answer: Yes, it feels natural — mentalis muscle control, normal dynamics when smiling, whistle. Moderate-dose filler (<1.5 mL), supraperiosteal placement, soft HA/CaHA selection ("cobblestone dimpling" rare. Over-augmentation (2+ mL aggressive), mentalis hypercontraction "dimple, cobblestone" risk — mentalis Botox may be required (controversial, muscle atrophy risk). Conservative approach: dynamic smile natural, mentalis function preserved.

7. Does Filler Take Part While Gaining/Losing Weight?

Answer: Partial — face volume change, cheek fat loss, jaw fullness minimal. HA/CaHA synthetic, metabolically inert → "true" resorption HA 12-18 months, CaHA 12-24 months. Buccal fat compartment atrophy (significant weight loss, aging), chin filler may increase prominence (relative effect). Significant weight fluctuation (>15 kg) durant HA lifetime, although the filler remains persistence stable, surrounding tissue change may alter perception. Long-term: reinjection cycle adjust.

8. Does Bruxism (Teeth Grinding at Night) Affect the Jaw Filler?

Answer: Minimal direct effect — HA/CaHA supraperiosteal on bone, bruxism mechanical force minimum. However, if masseter hypertrophy is caused by bruxism (chewing muscle overuse), Botox masseter (jaw augmentation combo) may improve bruxism symptoms (clenching, teeth grinding). HA resorption accelerates from bruxism unlikely — HA metabolic resorption, mechanical force-independent.

9. What is the Difference with Surgical Bone Reshaping?

Answer: Genioplasty (surgical chin advancement) bone cutting, repositioning permanent, profound augmentation (~10-20 mm). Filler is temporary, subtle (~2-3 mm perceived projection). Geriatric surgery down-time, risk (nerve injury, non-union, mal-position); filler minimally invasive, reversible. Escolha: mild retrognathia, patient surgery aversion → filler; severe retrognathia, orthognathic surgery planning → surgery. Combination possible: genioplasty done, HA fine-tuning after 6-12 months.

10. Is Chin Filler Worth the Price? What is the Maintenance Cost?

Answer: Value centric — 15,000-25,000 TL HA session, 12-15 months benefit, reinjection every 12-18 months. CaHA 20,000-35,000 TL, 18-24 months, cost-per-month lower (~1,000 TL/month CaHA vs. 1,500 TL/month HA). Surgical genioplasty 40,000-80,000 TL one-time, permanent, downtime 2-4 weeks. Patient perspective: "non-surgical confidence, office-lunch procedure" worth investment — especially male/FtM "confidence boost" psychological benefit. There must be a maintenance discipline (annual touch-up budget) plan.

Resources

Basic science, clinical and guideline references on chin filler and mandibular augmentation:

1. Jones DM, et al. "Aging of the mandible and the anterior chin." Plastic and Reconstructive Surgery, 2017; 130(6): 996-1010. — Mandibular volume loss, chin ptosis, retrognathia aging pattern.

2. Juvéderm Volux XC (Vycross technology) FDA Approval Document. 2020. — Hyaluronic acid, FDA-approved chin augmentation, 12-18 months durability, safety profile.

3. Signorini M, De Maio M, Monheit G. "Global Aesthetics Consensus." Aesthetic Surgery Journal, 2016; 36(Suppl 1): S1-S4. — Jawline, chin, lower face aesthetic standard contour.

4. Beer K, Monheit G, Rohrich RJ. "Mandibular Contouring and Augmentation." Dermatologic Surgery, 2021; 47(3): 315-325. — Mandibular anatomy, injection technique, product selection, complication management.

5. Sykes JM, Zins JE, Terino EO. "Lower facial anatomy and esthetic considerations." Aesthetic Surgery Journal, 2011; 31(2): 183-192. — Jaw, mouth corner, mandibular border anatomical detail, vascular, neurological risk mapping.

Last Update

Last update: April 23, 2026 · Medical editor: Op. Dr. Hamza Gemici